An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Part of paid clinical trials in Duarte, California.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT02750514
- Phase
- PHASE2
- Status
- Terminated
Conditions
- Advanced Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Nivolumab — BIOLOGICALArm associated with this intervention is closed. Nivolumab is no longer given as an active comparator.
- Dasatinib — DRUG
- Relatlimab — BIOLOGICAL
- Ipilimumab — BIOLOGICAL
- BMS-986205 — DRUGSpecified dose on specified days
Study Details
The purpose of this study is to determine whether Nivolumab, in combination with other therapies, is effective in patients with advanced Non-Small Cell lung cancer
Key Dates
- Start date
- May 9, 2016
- Status verified
- Feb 2021
- Primary completion
- Jan 29, 2020
- Completion
- Jan 29, 2020
Study Design
- Enrollment
- 295 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: NivolumabNivolumab Monotherapy - Arm associated with this intervention is closed. Nivolumab is no longer given as an active comparator
- Experimental: Nivolumab & DasatinibNivolumab in combination with Dasatinib
- Experimental: Nivolumab & RelatlimabNivolumab in combination with Relatlimab
- Experimental: Nivolumab & IpilimumabNivolumab in combination with Ipilimumab
- Experimental: Nivolumab & BMS-986205Nivolumab in combination with BMS- 986205
Primary Outcome Measure
Objective Response Rate (ORR) [ Time Frame: From first dose to 2 years following last dose (up to 30 months) ]
Locations (35)
Find similar trials in Duarte, CA
By research site
City of Hope National Medical Center· Duarte, CACedars-Sinai Medical Center· Los Angeles, CAUniversity of Californa, Los Angeles (UCLA)· Los Angeles, CAUniversity of Southern California (USC)· Los Angeles, CAHoag Memorial Hospital Presbyterian· Newport Beach, CAUniversity of California San Diego· San Diego, CA
Related Studies
- Psychophysical Studies of Cancer Therapy PainRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- AIMS Cancer Outcomes StudyRecruiting · Advanced Integrative Medical Science Institute · Seattle, Washington
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Artios Pharma Ltd · Birmingham, Alabama